发明名称 Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
摘要 Biocompatible, bioerodible implants and microspheres include latanoprost and a biodegradable polymer effective, when placed intraocular (such as into the subtenon space) to treat glaucoma.
申请公布号 US8771745(B2) 申请公布日期 2014.07.08
申请号 US201213596904 申请日期 2012.08.28
申请人 Allergan, Inc. 发明人 Robinson Michael R.;Liu Hui;Hughes Patrick M.;Spada Lon T.;Ghebremeskel Alazar N.
分类号 A61K9/14;A61K9/00 主分类号 A61K9/14
代理机构 代理人 Wine Laura L.;German Joel B.;Condino Debra D.
主权项 1. A method of treating glaucoma, the method comprising anterior sub-tenon administration to a patient with glaucoma of a 50-μl pharmaceutical composition consisting of: (a) a plurality of microspheres made from a PLGA and/or PLA; (b) 1242 micrograms of latanoprost contained by the microspheres, and; (c) 50 μl of a high viscosity hyaluronic acid, the high viscosity hyaluronic acid corresponding to a gel formed of 18 mg of a cross-linked hyaluronic acid in 1 ml of phosphate buffer at pH 7.2, the cross-linked hyaluronic acid having an average molecular weight of about 2 million Daltons, thereby treating the glaucoma.
地址 Irvine CA US